WASHINGTON — President Obama intends to nominate Dr. Margaret A. Hamburg, a former New York City health commissioner, to lead the Food and Drug Administration, sidestepping a battle between drug safety advocates and the drug industry, according to people briefed on the decision.
The administration is likely to announce the decision this week, these people said. Dr. Joshua Sharfstein, the health commissioner of Baltimore, who led the Obama administration’s transition team for the F.D.A., will become Dr. Hamburg’s chief deputy, these people said.
Dr. Hamburg, 53, succeeds Dr. Andrew C. von Eschenbach, who led the beleaguered agency from 2005 until last January and often had to deflect critics who accused the Bush administration of letting politics play too forceful a role in science policy.
Her selection, first reported Wednesday on the The Wall Street Journal’s Web site, was hailed by top public health officials and experts.
“Peggy has a deep commitment to the public health and, while she appreciates the vital role of industry, will surely focus on what is best for the public,” said Dr. Harvey V. Fineberg, president of the Institute of Medicine, the medical arm of the National Academy of Sciences.
Dr. Hamburg, who was appointed by Mayor David N. Dinkins as acting commissioner in 1991 and became commissioner the following year, was one of the few top officials asked to remain when Mayor Rudolph W. Giuliani took office in 1994. She was best known for developing a tuberculosis control program that produced sharp declines in the incidence of the disease in New York. Under her tenure, child immunization rates rose in the city.
http://www.nytimes.com/2009/03/12/us/politics/12hamburg.html?_r=1